DRUG Act
USA118th CongressHR-6283| House
| Updated: 12/17/2024
Mariannette Miller-Meeks
Republican Representative
Iowa
Cosponsors (25)
Diana Harshbarger (Republican)Mikie Sherrill (Democratic)Abigail Davis Spanberger (Democratic)Emanuel Cleaver (Democratic)Jefferson Van Drew (Republican)Neal P. Dunn (Republican)Aaron Bean (Republican)Kathy E. Manning (Democratic)Donald G. Davis (Democratic)Shri Thanedar (Democratic)Jake Auchincloss (Democratic)Thomas H. Kean (Republican)Sheila Cherfilus-McCormick (Democratic)Mike Flood (Republican)Richard Hudson (Republican)Glenn Grothman (Republican)Brandon Williams (Republican)Julia Letlow (Republican)David G. Valadao (Republican)Nanette Diaz Barragán (Democratic)Michael Lawler (Republican)Bradley Scott Schneider (Democratic)Jennifer A. Kiggans (Republican)Lori Chavez-DeRemer (Republican)Nicole Malliotakis (Republican)
Committees (6)
• Ways and Means Committee• Health Subcommittee• Health Subcommittee• Energy and Commerce Committee• Education and Workforce Committee• Oversight and Government Reform Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and the Workforce, and Oversight and Accountability, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Ordered to be Reported (Amended) by the Yeas and Nays: 29 - 11.
Committee Consideration and Mark-up Session Held
Referred to the Subcommittee on Health.
Health
Civil actions and liabilityHealth care costs and insurancePrescription drugsUser charges and fees
DRUG Act
USA118th CongressHR-6283| House
| Updated: 12/17/2024
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and the Workforce, and Oversight and Accountability, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Ordered to be Reported (Amended) by the Yeas and Nays: 29 - 11.
Committee Consideration and Mark-up Session Held
Referred to the Subcommittee on Health.
Mariannette Miller-Meeks
Republican Representative
Iowa
Cosponsors (25)
Diana Harshbarger (Republican)Mikie Sherrill (Democratic)Abigail Davis Spanberger (Democratic)Emanuel Cleaver (Democratic)Jefferson Van Drew (Republican)Neal P. Dunn (Republican)Aaron Bean (Republican)Kathy E. Manning (Democratic)Donald G. Davis (Democratic)Shri Thanedar (Democratic)Jake Auchincloss (Democratic)Thomas H. Kean (Republican)Sheila Cherfilus-McCormick (Democratic)Mike Flood (Republican)Richard Hudson (Republican)Glenn Grothman (Republican)Brandon Williams (Republican)Julia Letlow (Republican)David G. Valadao (Republican)Nanette Diaz Barragán (Democratic)Michael Lawler (Republican)Bradley Scott Schneider (Democratic)Jennifer A. Kiggans (Republican)Lori Chavez-DeRemer (Republican)Nicole Malliotakis (Republican)
Committees (6)
• Ways and Means Committee• Health Subcommittee• Health Subcommittee• Energy and Commerce Committee• Education and Workforce Committee• Oversight and Government Reform Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Civil actions and liabilityHealth care costs and insurancePrescription drugsUser charges and fees